Jump Financial’s Apellis Pharmaceuticals APLS Stock Holding History

Jump Financial’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-291,488	Closed	-$11.7M	–	2007
2026 Q1	$11.7M	Buy	291,488 +97,612	+50%	+$2.1M	0.16%	144
2025 Q4	$4.87M	Sell	193,876 -83,772	-30%	-$1.97M	0.06%	372
2025 Q3	$6.28M	Sell	277,648 -281,020	-50%	-$6.55M	0.08%	340
2025 Q2	$9.67M	Buy	558,668 +293,075	+110%	+$5.43M	0.1%	248
2025 Q1	$5.81M	Buy	+265,593	New	+$7.34M	0.08%	307
2023 Q4	–	Sell	-9,029	Closed	-$343K	–	1757
2023 Q3	$343K	Buy	9,029 +5,707	+172%	+$251K	0.01%	1230
2023 Q2	$303K	Buy	+3,322	New	+$287K	0.01%	1296
2021 Q3	–	Sell	-3,200	Closed	-$202K	–	1084
2021 Q2	$202K	Buy	+3,200	New	+$165K	0.02%	866
2021 Q1	–	Sell	-9,797	Closed	-$561K	–	921
2020 Q4	$561K	Buy	+9,797	New	+$414K	0.1%	342

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jump Financial's APLS Position: Q2 2026 in Review

Jump Financial sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 291,488 shares — an estimated $11.7M sold.

Jump Financial first reported a position in APLS in Q4 2020 and held it in 9 quarters. The position peaked at $11.7M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Jump Financial reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jump Financial sold 291,488 Apellis Pharmaceuticals shares in Q2 2026, an estimated $11.7M.
Jump Financial first reported a position in Apellis Pharmaceuticals in Q4 2020 and held it in 9 quarters.
Jump Financial's Apellis Pharmaceuticals position peaked at $11.7M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.